Search results
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 18 hours agoAdditionally, towards the end of last year, Roche also bought Roivant’s ulcerative colitis drug, RG-6631 (RVT-3101), for the high price tag of $7.1bn....
FDA once again stands athwart biomedical innovation, yelling 'stop!'
Reason.com· 3 days agoAs earlier threatened, the Food and Drug Administration (FDA) has just issued new rules that will...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 2 days agoEli Lilly 's raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that the long-term Eli Lilly ...
FDA moves to regulate some tests it says may be unreliable
Anchorage Daily News· 3 days agoThe Food and Drug Administration has finalized a divisive plan to regulate laboratory medical tests...
NKGen Biotech gears up for Parkinson's trial after FDA nod By Investing.com
Investing.com· 3 days ago(NASDAQ: NKGN), a clinical-stage biotech company, has received clearance from the U.S. Food and Drug...
The little nonprofit behind a big Covid theory
Politico· 1 day agoWitty expects that notification will take “several months,” and the company will offer free identity-theft protections for two years. ALZHEIMER’S
To save lives, the FDA must change how it evaluates rare disease treatments
Salon via Yahoo News· 2 days agoThat's not necessarily because scientists and clinicians don't know how to treat them. It's because...
FDA finalizes lab developed test rule despite industry opposition
MedTech Dive via Yahoo Finance· 4 days ago“LDTs are being used more widely than ever before – for use in newborn screening, to help predict a...
Cassidy bashes new FDA testing rule
Axios· 3 days agoSenate HELP Committee Ranking Member Bill Cassidy is taking the FDA to task for its new rule increasing oversight of laboratory-developed tests. Why it...
To save lives, the FDA must change how it evaluates rare disease treatments
Salon.com· 2 days agoFor some conditions, few approved treatments exist. Without accelerated approval, the FDA is failing...
